Phosphate Binders in CKD: ‟New Kids on the Block”
DOI:
https://doi.org/10.53778/pjkd31089Palavras-chave:
hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxideResumo
Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.
Downloads
Publicado
Edição
Seção
Licença
Direitos autorais (c) 2021 Muhammad Umair Afzal, Shafeeq Cheema

Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial 4.0 International License.
